Platinum Corporate Members
Amgen
At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.
Bristol Myers Squibb
Bristol Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
GlaxoSmithKline
GlaxoSmithKline is a science-led global healthcare company with a mission to help people do more, feel better, live longer. We research, manufacture and make available a broad range of medicines, vaccines and consumer healthcare products. Visit our exhibit for information about our products and resources.
Horizon Therapeutics
At Horizon, we define our success by a different set of numbers: the number of lives touched, the number of lives changed, the number of lives saved. As we build a growing pipeline and explore all potential uses for our medicines, we strive to make a powerful difference for our patients, their caregivers, and physicians every day.
Novartis
Our mission at Novartis is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues and develop breakthrough treatments, and find new ways to deliver them to as many people as possible.
Pfizer
Pfizer Corporate Responsibility believes that all individuals, everywhere, deserve access to quality healthcare and the opportunity to lead healthy lives. We combine traditional philanthropic methods with novel approaches that create an enduring and meaningful impact on public-health systems to facilitate access to healthcare for under-served communities around the world.
Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Sanofi Genzyme Regeneron
Regeneron and Sanofi Genzyme are committed to investigating new approaches that address unmet medical needs in inflammatory and immunological diseases. Our work is focused in the areas of rare diseases, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.
Diamond Corporate Members
Mallinckrodt Pharmaceuticals
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. To learn more visit www.mallinckrodt.com.
UCB
At UCB, patients are at the heart of everything we do. Since UCB was established in the U.S. in 1994, the U.S. affiliate of UCB has continuously maintained invaluable programs for patients, healthcare professionals, caregivers and patient communities. Many of the programs we support are noted for their innovative and pioneering work in healthcare.
Gold Corporate Member
Lilly
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. To learn more, visit www.lilly.com.
Sandoz
Sandoz is a pioneer and global leader in biosimilar medicines. Our mission is to discover new ways to improve and extend people’s lives, and we are committed to playing a leading role in improving access to medicine worldwide.
Silver Corporate Members
AbbVie
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Exagen
Exagen, Inc. is a commercial stage life sciences company that is patient focused and discovery driven. We serve patients and healthcare providers across the U.S. in the diagnosis, prognosis, and management of connective tissue diseases. By leveraging our patented and validated technology we can help get to the real cause of a patient’s symptoms and guide their journey to improved health.
Genentech
As the founders of the biotechnology industry, our goal is to use the power of genetic engineering and advanced technologies to make medicines that address unmet medical needs, and help millions of people worldwide.
Janssen
For more than 30 years, Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative “firsts,” Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, we dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.
Vectra
Vectra simultaneously measures 12 key biomarkers associated with RA disease activity and combines them into a single score between 1 and 100 (where a lower score indicates less disease activity). By providing an objective and reproducible measure of RA disease activity that can be used alongside existing assessment tools, Vectra helps patients with RA and their healthcare professionals to work together in determining individualized treatment goals.
Walgreens
Walgreens, one of the nation’s largest drugstore chains, is included in Walgreens Boots Alliance, Inc., the first global pharmacy-led, health and wellbeing enterprise. Walgreens is focused on expert specialty pharmacy care. Our pharmacists and pharmacy technicians go beyond filling prescriptions. Whether it’s taking the lead on prior authorizations, making limited-distribution drugs accessible, helping to ease patient copay costs or providing medication adherence services, our team understands rheumatology patient needs and works with providers to support the prescribed regimen.
National Advocacy Sponsors
Bristol Myers Squibb
Bristol Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Pfizer
Pfizer Corporate Responsibility believes that all individuals, everywhere, deserve access to quality healthcare and the opportunity to lead healthy lives. We combine traditional philanthropic methods with novel approaches that create an enduring and meaningful impact on public-health systems to facilitate access to healthcare for under-served communities around the world.
Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Sanofi Genzyme Regeneron
Regeneron and Sanofi Genzyme are committed to investigating new approaches that address unmet medical needs in inflammatory and immunological diseases. Our work is focused in the areas of rare diseases, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.